NCT01445288 2026-02-20
Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
National Institutes of Health Clinical Center (CC)
Completed
Clinical Trials
48 trialsNCT07333976 2026-01-12
o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer
Tri-Service General Hospital
Phase 2 Completed
NCT04150913 2025-11-25
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
Massachusetts General Hospital
Phase 2 Completed
NCT00727922 2025-11-20
MnDPDP-K04
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed
NCT04583124 2025-11-18
ATENTO
Universidad de Granada
Phase NA Completed
NCT01399372 2023-07-20
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Radiation Therapy Oncology Group
Phase 2 Completed
NCT01372774 2022-09-16
Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00039780 2022-07-13
Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel
BioNumerik Pharmaceuticals, Inc.
Phase 3 Completed
NCT00792142 2021-08-19
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
City of Hope Medical Center
Phase 2 Completed
NCT01381718 2021-08-13
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
University of South Florida
Phase 2 Completed
NCT02864030 2021-03-04
PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
Oncologia Medica dell'Ospedale Fatebenefratelli
Phase 4 Completed
NCT01913093 2020-10-08
NPG
The Hospital for Sick Children
Completed
NCT02890030 2020-04-08
The Platinum Study Comparison Group
Indiana University
Completed
NCT00001807 2019-04-24
(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy
National Institutes of Health Clinical Center (CC)
Completed
NCT00452868 2018-09-07
Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT00068445 2018-05-04
Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00755313 2017-11-24
Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer
University of California, San Francisco
Completed
NCT00516503 2017-08-24
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00566852 2017-08-21
Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00775645 2017-08-14
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo
SWOG Cancer Research Network
Phase 3 Completed
NCT00437060 2017-07-21
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Children's Oncology Group
Completed
NCT01982591 2017-06-15
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Fox Chase Cancer Center
Completed
NCT00952848 2017-03-29
Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy
Virginia Commonwealth University
Phase 2 Completed
NCT02311907 2017-02-23
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00365768 2016-09-09
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
Columbia University
Phase 2 Completed
NCT00316914 2016-08-11
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00860041 2016-07-14
Acute Pain Caused by Paclitaxel in Patients With Cancer
Alliance for Clinical Trials in Oncology
Completed
NCT00046891 2016-07-06
EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00363129 2016-07-06
Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00027963 2016-07-04
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00305188 2016-05-04
Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.
Sanofi
Phase 3 Completed
NCT01763710 2016-03-29
neurabrax
Fundacion Oncosur
Phase 2 Completed
NCT00471445 2015-11-09
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
University of Rochester
Phase 3 Completed
NCT00018967 2015-04-30
Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
National Cancer Institute (NCI)
Phase NA Completed
NCT00666484 2014-12-04
Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma
University College, London
Phase 2 Completed
NCT00305799 2014-11-24
Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors
Case Comprehensive Cancer Center
Completed
NCT00028509 2014-02-13
Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201
Children's Oncology Group
Completed
NCT00085176 2014-01-30
Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia
Children's Oncology Group
Completed
NCT00727831 2014-01-27
Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
University College, London
Phase 1/2 Completed
NCT01196442 2013-08-23
Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer
Virginia Commonwealth University
Phase NA Completed
NCT00058071 2013-07-09
Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer
GOG Foundation
Phase 3 Completed
NCT00003569 2013-01-31
Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel
Roswell Park Cancer Institute
Completed
NCT00078845 2012-10-17
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00003072 2012-09-21
Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer
University of California, San Francisco
Phase 2 Completed
NCT00263861 2010-06-11
Nerve Function in Older Diabetic Patients Who Are Undergoing Chemotherapy for Metastatic Solid Tumors
Case Comprehensive Cancer Center
Phase NA Completed
NCT00281853 2010-06-11
Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer
Case Comprehensive Cancer Center
Completed
NCT00001689 2008-03-04
A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00272051 2006-09-13
XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy
Sanofi
Phase 3 Completed